Company / Current Assets
Twist Bioscience Corp Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$333.0M
FY2025
5-year range
$333.0M / $596.5M
FY2021-FY2025
Trend
-4.0%
vs FY2024
Sector context
#154 of 215
Health Care
What the data says
At $333M, Twist Bioscience Corp's current assets ranks #154 of 215 in the Health Care sector. Current Assets has declined for 3 consecutive years, from $596M in FY2022 to $333M in FY2025.
Based on SEC 10-K filings.
$333M in FY2025 with a 5-year CAGR of -0.1%.
Declined from $424M to $333M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -17.7%
- 5-Year CAGR
- -0.1%
- 10-Year CAGR
- -
Sector benchmark
#154 of 215 in Health CareTop 72% of 215This company $333.0M Sector average $2.5B
▼
-86.9% below sector average
Key checks
Key Insights
- Twist Bioscience Corp's current assets has declined for 3 consecutive years.
- 5-year CAGR of -0.1%, indicating a declining trend.
- In FY2025, current assets decreased 4.0% year-over-year.
- Ranks #154 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $333.0M | -4.0% |
| FY2024 | $346.8M | -18.3% |
| FY2023 | $424.3M | -28.9% |
| FY2022 | $596.5M | +9.1% |
| FY2021 | $546.5M | +63.2% |
| FY2020 | $334.9M | +109.1% |
| FY2019 | $160.1M | +67.4% |
| FY2018 | $95.7M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026